Results 101 to 110 of about 42,805 (221)

Determining the date of diagnosis – is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care [PDF]

open access: yes, 2009
Background Studies of cancer incidence and early management will increasingly draw on routine electronic patient records. However, data may be incomplete or inaccurate.
A Majeed   +27 more
core   +3 more sources

Ovarialkarzinom: präoperatives CA125 als Prognosemarker [PDF]

open access: yesgynäkologie + geburtshilfe, 2012
Bei den malignen epithelialen Ovarialtumoren lassen sich diejenigen mit niedrigem Malignitatspotenzial abgrenzen. Bei der Beurteilung des Therapieerfolges im Sinne einer 5-Jahres-Rezidivfreiheit und 5-Jahres-Gesamtuberlebenszeit erwiesen sich erhohte CA125-Spiegel als unabhangiger prognostischer Biomarker.
openaire   +2 more sources

CT and MRI Manifestations of Pancreatic Hemangioma: A Literature Review and a New Case Report

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Pancreatic hemangioma is an extremely rare benign tumor occurring in the pancreas. Preoperative diagnosis is challenging due to its lack of specificity in clinical manifestations and imaging examinations. A pancreatic lesion was found during physical examination of a 54‐year‐old woman who had no symptoms of abdominal discomfort.
Jing Zhang   +3 more
wiley   +1 more source

Two Cases of Macroglobulinemia with Elevated Serum CA125: Case Reports and Literature Review

open access: yesCancer Management and Research
Huiying Zhao,1,* Ling Qin,2,* Geng Wang,1 Jianying Li,1 Yuan Huang,1 Jie Niu,1 Xuzhen Qin1 1Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of ...
Zhao H   +6 more
doaj  

T‐cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first‐in‐human dose‐escalation trial for platinum‐resistant advanced ovarian cancer

open access: yesCancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Ovarian cancer remains a formidable therapeutic challenge due to late diagnosis, high recurrence rates, and limited treatment options. Mesothelin (MSLN) is highly expressed in ovarian cancer, making it a promising target for immunotherapy.
Yiyang Shan   +7 more
wiley   +1 more source

Gynaecological surveillance in high risk women [PDF]

open access: yes, 2016
Increasing availability of genetic testing and falling costs of the tests suggests that growing numbers of unaffected women will be identified worldwide who are at increased risk of gynaecological malignancies.
Dilley, J, Gentry-Maharaj, A, Menon, U
core  

Role of galectin-3 combined with multi-detector contrast enhanced computed tomography in predicting disease recurrence in patients with ovarian cancer [PDF]

open access: yes, 2017
Galectin-3 (Gal-3) is an endogenous β-galactoside-binding lectin, playing an important role in the pathogenesis of multiple malignancies. Aim of the study was to evaluate in a group of patients treated for ovarian cancer (EOC), the role of Gal-3 ...
ANASTASI, Emanuela   +9 more
core   +1 more source

Primary Mediastinal Malignant Melanoma Presenting With Pleural Effusion: A Case Report

open access: yesCancer Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Primary mediastinal malignant melanoma (PMMM) presenting with pleural effusion as the initial manifestation is exceedingly rare, presenting significant diagnostic and therapeutic challenges. This article reports a case of PMMM that initially manifested as pleural effusion and includes a review of the relevant literature.
Minlian Nong   +4 more
wiley   +1 more source

Determination of reference intervals of serum levels of human epididymis protein 4 (HE4) in Chinese women [PDF]

open access: yes, 2015
The detailed numbers of subjects from different centers.
Aimin Zhang   +20 more
core   +2 more sources

MUC16/CA125 in cancer: new advances

open access: yesClinica Chimica Acta
MUC16/CA125 is a common diagnostic marker for many types of cancer. However, due to the widespread expression of MUC16 in cancer, its specificity and sensitivity as a target are poor, which severely limits its clinical application. In recent years, various studies have shown that the clinical application potential of MUC16/CA125 has been greatly ...
Xin-Yu, Zhang   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy